Alpha Profiles · Company Profile
Vanda Pharmaceuticals Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/vanda-pharmaceuticals-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: VNDA
- Verification
- Partially verified
- Last reviewed
- 2026-10-01T04:46:41.376712+00:00
Overview
Alpha's canonical identity and public leadership record for Vanda Pharmaceuticals Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
5 public recordsSenior Vice President, Business Development
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
Senior Vice President, Chief Marketing Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
Senior Vice President, Chief Financial Officer and Treasurer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
President, Chief Executive Officer and Chairman of the Board
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
Senior Vice President, General Counsel and Secretary
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 1, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
10 public recordsPresident, Chief Executive Officer and Chairman of the Board
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2019
- Confidence
- 88%
- Evidence
- DEF 14A vnda-20260423.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2026
- Confidence
- 88%
- Evidence
- DEF 14A vnda-20260423.htmApr 23, 2026
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2003
- Confidence
- 88%
- Evidence
- DEF 14A vnda-20260423.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2019
- Confidence
- 88%
- Evidence
- DEF 14A vnda-20260423.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2005
- Confidence
- 88%
- Evidence
- DEF 14A vnda-20260423.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 88%
- Evidence
- DEF 14A vnda-20260423.htmApr 23, 2026
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 95%
- Evidence
- SEC DEF 14A 0001628280-26-026893Apr 23, 2026
Committees
1 public recordMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Granted in February 2026 (for 2025 Compensation) Committee
- Chair
- Not stated
- Members
- Mihael H. Polymeropoulos
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-01T04:46:41.376712+00:00